The present invention, in some embodiments thereof, relates to a method for indicating the position of a door and, more particularly, but not exclusively, to a method for indicating the position of a medical device door.
Following are some examples of some embodiments of the invention:
Example 1. A drug delivery device, comprising: housing, wherein said housing defines an opening and a chamber for a drug cartridge;
a movable door connected to said housing, having a range of movement between a fully open position and a closed position, wherein said door blocks access to said opening when said door is in said closed position;
a biasing element connected to said housing or said door, wherein said biasing element is positioned to interfere with the movement of said door by applying an opening force to open said door when said range of movement of said door is near said closed position, thus defining an exclusion zone;
a locking mechanism between said door and said housing, said locking mechanism applies a locking force on said door greater and in an opposite direction to the force applied by said biasing element.
Example 2. The device of example 1, further comprising a drug dispensing mechanism; wherein closing of said movable door engages said drug dispensing mechanism to release drug from said drug cartridge.
Example 3. The device of examples 1 or 2, wherein said movable door is connected to said housing via a hinge, wherein said locking mechanism is positioned in a distance from said hinge at the contact point between said movable door and said housing.
Example 4. The device of any of the previous examples, wherein said movable door further comprising a hinge support, wherein when said movable door is closed said hinge support pushes said biasing element with a closing force which is greater than said opening force.
Example 5. The device of example 4, wherein when said opening force is greater than said closing force said biasing element moves said movable door to a perceptibly open position by pushing said hinge support.
Example 6. The device of example 4, wherein said movable door protrudes at least 4 mm from said housing when said movable door is in said perceptibly open position.
Example 7. The device of any of examples 3 to 6, wherein said biasing element applies said opening force when during the rotation of said movable door on said hinge said door reaches the last 20-30% of said range of movement.
Example 8. The device of any of examples 3 to 6, wherein said biasing element applies said opening force in the last 20-30 degrees of the rotation of said movable door on said hinge towards a closing position.
Example 9. The device of any one of examples 3 to 8, wherein said biasing element is positioned within said hinge.
Example 10. The device of any of the previous examples, wherein said door interlocks with locking geometries on said housing for locking said door.
Example 11. The device of any of the previous examples, wherein said locking mechanism irreversibly locks said movable door.
Example 12. The device of examples 1 or 2, wherein said door is a sliding door.
Example 13. The device of any of the previous examples, wherein said biasing element is a leaf spring, and/or a torsion spring.
Example 14. The device of any of the previous example, wherein said biasing element is a deformable element configured for elasticity deforming.
Example 15. The device of any of the previous examples, wherein said door further comprises a transmission to couple between a motor of said device and a drug cartridge when said door is in said closed position.
Example 16. A method for visually indicating that a door of a drug delivery device is open, comprising:
receiving by said door a closing force to move said door;
detecting that said door is not closed;
pushing said door with an opening force by a biasing element, to a perceptibly open position; and
indicating that said door is open by identifying said perceptibly open position of said door compared to said drug delivery device housing.
Example 17. The method of example 16, wherein said indicating further comprises indicating that said door is open by identifying at least one gap between said door and said drug delivery device housing.
Example 18. The method of examples 16 or 17, wherein said receiving further comprises receiving said closing force to move said door, wherein said closing force is greater than said opening force.
Example 19. The method of anyone of examples 16 to 18, wherein said detecting further comprises detecting that said door is not locked by a locking mechanism of said door and/or housing of said drug delivery device.
Example 20. The method of anyone of examples 16 to 19, wherein said indicating further comprises indicating that said door is open by visually identifying said perceptibly open position.
Example 21. The method of anyone of examples 16 to 19, wherein said indicating further comprises indicating that said door is open by touching said door and said drug delivery device housing.
Unless otherwise defined, all technical and/or scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention pertains. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of embodiments of the invention, exemplary methods and/or materials are described below. In case of conflict, the patent specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and are not intended to be necessarily limiting.
The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.
Some embodiments of the invention are herein described, by way of example only, with reference to the accompanying drawings and images. With specific reference now to the drawings in detail, it is stressed that the particulars shown are by way of example and for purposes of illustrative discussion of embodiments of the invention. In this regard, the description taken with the drawings makes apparent to those skilled in the art how embodiments of the invention may be practiced.
In the drawings:
The present invention, in some embodiments thereof, relates to a method for indicating the position of a door and, more particularly, but not exclusively, to a method for indicating the position of a medical device door.
An aspect of some embodiments relates to preventing a medical device door from being in an exclusion zone. In some embodiments, the exclusion zone is located near the closing position of the door. Alternatively, the exclusion zone is located at the last 50% of the medical device door range of movement, for example the last 5, 10, 15, 20%. In some embodiments, the exclusion zone is located at the last 25 degrees, for example last 20, 15, 10 degrees of the rotation of the device door towards a closed position.
In some embodiments, a biasing element applies a force on the door, when the door is within the exclusion zone. In some embodiments, the biasing element pushes the door open to a perceptibly open position. In some embodiments, when the door is at a perceptibly open position, a user of the device receives a clear visual indication that the door is open. Alternatively, when the door is at a perceptibly open position, a user can feel by touching the door and/or the device that the door is open. In some embodiments, for example, when the door is at a perceptibly open position the door protrudes at least 2 mm, for example 3, 4, 5, 6, 7 mm, from the device casing. In some embodiments, a potential advantage of having a biasing element which generates a limited range exclusion zone is that the biasing element does not interfere with access into the device when it pushes the door wide open. Additionally, having a device with a door wide open, for example when the door significantly protrudes out from the casing, may lead to problems during packaging and/or transportation of the device.
In some embodiments, a user applies force on the door in an opposite direction to the force applied by the biasing element, for example to move the door to a closing position. In some embodiments, the force applied by the user is larger than the opening force applied by the biasing element. In some embodiments, if the door is not further pushed by a user, then the biasing element pushes the door to the perceptibly open position.
In some embodiments, when the door is pushed to a closed position, a closing mechanism located on the door and/or on the medical device applies a greater force compared to the force applied by the biasing element. In some embodiments, the locking mechanism can be released, for example to allow opening of the door to a perceptibly open position by the biasing element. Alternatively, the locking element prevents the re-opening of the door, for example to ensure that the door remains closed, for example in case of a single use device.
Before explaining at least one embodiment of the invention in detail, it is to be understood that the invention is not necessarily limited in its application to the details of construction and the arrangement of the components and/or methods set forth in the following description and/or illustrated in the drawings and/or the Examples. The invention is capable of other embodiments or of being practiced or carried out in various ways.
In some embodiments, a drug dispensing mechanism of a drug delivery device, for example medical device 100 in
In some embodiments, if the door is not closed or is in a nearly closed position, for example as shown in
In some embodiments, in order to indicate to a user that the door is not closed, the door 104 is placed in a perceptibly open position. In some embodiments, in a perceptibly open position the gap formed between the door 104 and the housing 102, for example gap 105 is wide enough to visually indicate and/or to be identified by touch that the door is not closed. In some embodiments, the gap 107 formed between the door 104 and the upper part 103 of housing 102 is also visible and can be identified by touching the outer surface of the medical device, for example the upper part of the medical device 100 In some embodiments, when a user receives the indication that the door is not closed, he can then apply more force to close the door and optionally to ensure locking of the door.
Exemplary Formation of an Exclusion Zone
According to some embodiments, in order to place the door in a perceptibly open position, an exclusion zone is formed. In some embodiments, the door is not allowed to be positioned within the exclusion zone, unless a user applies force on the door.
Reference is now made to
According to some exemplary embodiments, a biasing element for example an elastic biasing element or a deformable biasing element applies force on the door when the door is reaching a closed position. In some embodiments, the biasing element continuously applies force on the door from a near closed position until the door reaches a closing position. In some embodiments, an exclusion zone as long as the biasing element applies force on the door. In some embodiments, the biasing element applies enough force to move the door to perceptibly open position if the total force applied on the door is in the direction of the force applied by the biasing element.
According to some exemplary embodiments, when the door is pushed from an open position to a closing position of 0 degrees between the door and the device housing, a biasing element starts to apply force on the door when the door opening degree is less than 90 degrees. In some embodiments, the biasing element applies force on the door until the door reaches an angle of 0 degrees. Optionally, the biasing element applies force on the door when the door is closed or locked.
According to some exemplary embodiments, when the door opening angle degree is less than 90 degrees, a biasing element, for example a torsion spring gradually applies force on the door. In some embodiments, for example as seen in graph 204 a user needs to apply force larger than the force applied by the torsion spring and in an opposite direction until the door is closed. In some embodiments, the increase in force applied by the user against the torsion spring is more gradual compared to the force that needs to be applied against a leaf spring as seen in graph 202. In some embodiments, the amount of force that needs to be applied by a user to close the door depends on the elasticity of the biasing element.
In some embodiments, the leaf spring starts to apply force on the door when the door angle is less than 45 degrees. In some embodiments, the leaf spring and the torsion spring form an exclusion zone 206, however the exclusion zone formed by the torsion spring is larger compared to the exclusion zone formed by the leaf spring. In some embodiments, force application in wider opening angles, for example by the torsion spring allows to form larger exclusion zones. In some embodiments, a larger exclusion zone allows for example, a better indication that the door of the medical device is open.
According to some exemplary embodiments, when the door is closed or reaches a near closing position, a locking mechanism locks the door. In some embodiments, the locking mechanism applies a force larger than the biasing element. In some embodiments, when the door is locked the force applied by the user to keep the door closed is zero, as shown in graphs 202 and 204.
Exemplary Process for Closing a Door
According to some exemplary embodiments, a medical device user, closes a door of the device to allow the device to operate according to a desired activation process. Reference is now made to
According to some exemplary embodiments, the door is closed by a user of the medical device at 302. In some embodiments, the user closes the door by applying sufficient force on the door to allow the door movement to a closing position. In some embodiments, the force applied by the user is larger than the force applied by a biasing element. Additionally, the force applied by the user is in and in an opposite direction to the force applied by the biasing element. In some embodiments, the user applies force on the door, to move the door to a locking position
According to some exemplary embodiments, the door movement is estimated at 304. In some embodiments, if the door moves less than 50% of the door range of movement, then the user visualizes the door position at 306, for example to receive a visual indication about the door position. In some embodiments, following the visualization of the door position, the user applies additional force to close the door at 312.
According to some exemplary embodiments, if the door moves more than 50% of the door range of movement, then the user checks whether the door is locked at 308. In some embodiments, if the door is locked, then no further actions are requires. Alternatively, if the door is not locked then a biasing element pushes the door open at 310. In some embodiments, the biasing element pushes the door to a perceptibly open position.
According to some exemplary embodiments, the user visualizes the door position at 306. In some embodiments, the user visualizes that the door is at a perceptibly open position at 306, optionally by visualizing a gap between the door and the device casing, for example gap 108 shown in
According to some exemplary embodiments, if the door is visualized in a perceptibly open position, then the user applies additional force to close the door at 312. In some embodiments, the user applies a larger force on the door at 312. In some embodiments, after the additional force is applied by the user, the door movement is estimated at 304, as previously described.
Exemplary Closing of a Rotating Door
Reference is now made to
According to some exemplary embodiments, medical device 400 comprises a movable door, for example rotating door 404 and housing 402, and a biasing element 406 connected to housing 402. In some embodiments, the rotating door 404 is connected to housing 402 via a hinge 405 which allows the axial rotation of the rotating door 404. In some embodiments a hinge support 403 is connected to rotating door 404. In some embodiments, the biasing element is positioned on the left side of the hinge support. Alternatively, for example when the hinge is placed on the right side of the biasing element, the hinge support is positioned on the left side of the biasing element.
According to some exemplary embodiments, for example as shown in
According to some exemplary embodiments, for example as shown in
According to some exemplary embodiments, for example as shown in
Reference is now made to
According to some exemplary embodiments, for example as shown in
Reference is now made to
According to some exemplary embodiments, for example as shown in
Exemplary Closing of a Sliding Door
Reference is now made to
According to some exemplary embodiments, medical device 500 comprises a sliding door 502, housing 504 and a biasing element 506 connected to housing 504. In some embodiments, for example as shown in
According to some exemplary embodiments, for example as shown in
According to some exemplary embodiments, in order to further push and close the sliding door 502, the user applies force in direction 508 in an opposite direction to the force applied by the biasing element, for example as shown in
According to some exemplary embodiments, if the sliding door 502 is pushed by the user for a sufficient time period with a force larger than the force applied by biasing element, then the door is closed, for example as shown in
Reference is now made to
According to some exemplary embodiments, when sliding door 522 of medical device 520 is in an open position, for example as shown in
Exemplary Drug Delivery Device
Reference is now made to
According to some exemplary embodiments, a drug delivery device 600 comprising housing 602 and a movable door, for example rotating door 604 connected to housing 602 via hinge 606. In some embodiments, housing 602 defines a chamber for a drug reservoir, for example cartridge 614. In some embodiments, cartridge 614 stores drug molecules that are released when a drug dispensing mechanism of device 600 is engaged.
According to some exemplary embodiments, drug delivery device 600 further comprising a biasing element, for example a leaf spring 610 and/or torsion spring 612, connected to housing 602. In some embodiments, door 604 is connected to hinge 606 via hinge support 608. In some embodiments, when the door 604 is in a fully open position, for example as shown in
According to some exemplary embodiments, when the door 604 moves in direction 620, the door applies additional force on the biasing element. Alternatively, when the door 604 moves in direction 620, the hinge support 608 applies additional force on the biasing element, for example on the leaf spring 610. Optionally, when the door moves in direction 620 an increasing force is applied on the biasing element.
According to some exemplary embodiments, door 604 is further pushed in direction 620 with a force greater than the force applied by the biasing element in order to reach a closing position. In some embodiments, when door 604 is closed, for example as shown in
According to some exemplary embodiments, if door 604 is not locked and there is no force applied in direction 620, the biasing element, for example leaf spring 610 or torsion spring 612 pushes the door back to the perceptibly open position, for example the perceptibly open position shown in
According to some exemplary embodiments, both a torsion spring and a leaf spring are connected to the housing of a medical device and apply force on the door. In some embodiments, the torsion spring applies force on the door at least at the last 50% of the door range of movement towards closure. In some embodiments, the leaf spring applies additional force on the door at least at the last 30% of the door range of movement towards closure.
According to some exemplary embodiments, when door 604 remains closed or locked, a drug dispensing mechanism of the drug delivery device is engaged, for example to allow drug dispensing from cartridge 614 upon device activation. In some embodiments, when door 604 is partially open, for example when door 604 is in a perceptibly open position, drug dispensing mechanism is not engaged and drug is not released from cartridge 614 when the device is activated.
According to some exemplary embodiments, the biasing element is an elastic element made from metal. Alternatively, the biasing element is a deformable element with a limited elastic range and is made, for example from plastic or elastomer.
Exemplary Engaging Drug Dispensing Mechanism
Reference is now made to
According to some exemplary embodiments, medical device 650 comprising a motor mechanism 710 and a cartridge mechanism 712 of drug cartridge 614. In some embodiments, when door 604 is not closed for example when door is in a perceptibly open position the cartridge mechanism 712 is not engaged to motor mechanism 710. In some embodiments, when cartridge mechanism 712 is not engaged, a drug cannot be dispensed from cartridge 614, optionally even if the medical device 650 is activated by a user.
According to some exemplary embodiments, when door 604 is closed, for example by applying additional force against the biasing element 612, the cartridge mechanism 712 is engaged to motor mechanism 710. In some embodiments, a door transmission 714 is connected to door 604 and is coupled between the motor mechanism 710 and the cartridge mechanism 712, for example as shown in
It is expected that during the life of a patent maturing from this application many relevant biasing elements will be developed; the scope of the term biasing element is intended to include all such new technologies a priori.
As used herein with reference to quantity or value, the term “about” means “within ±10% of”.
The terms “comprises”, “comprising”, “includes”, “including”, “has”, “having” and their conjugates mean “including but not limited to”.
The term “consisting of” means “including and limited to”.
The term “consisting essentially of” means that the composition, method or structure may include additional ingredients, steps and/or parts, but only if the additional ingredients, steps and/or parts do not materially alter the basic and novel characteristics of the claimed composition, method or structure.
As used herein, the singular forms “a”, “an” and “the” include plural references unless the context clearly dictates otherwise. For example, the term “a compound” or “at least one compound” may include a plurality of compounds, including mixtures thereof.
Throughout this application, embodiments of this invention may be presented with reference to a range format. It should be understood that the description in range format is merely for convenience and brevity and should not be construed as an inflexible limitation on the scope of the invention. Accordingly, the description of a range should be considered to have specifically disclosed all the possible subranges as well as individual numerical values within that range. For example, description of a range such as “from 1 to 6” should be considered to have specifically disclosed subranges such as “from 1 to 3”, “from 1 to 4”, “from 1 to 5”, “from 2 to 4”, “from 2 to 6”, “from 3 to 6”, etc.; as well as individual numbers within that range, for example, 1, 2, 3, 4, 5, and 6. This applies regardless of the breadth of the range.
Whenever a numerical range is indicated herein (for example “10-15”, “10 to 15”, or any pair of numbers linked by these another such range indication), it is meant to include any number (fractional or integral) within the indicated range limits, including the range limits, unless the context clearly dictates otherwise. The phrases “range/ranging/ranges between” a first indicate number and a second indicate number and “range/ranging/ranges from” a first indicate number “to”, “up to”, “until” or “through” (or another such range-indicating term) a second indicate number are used herein interchangeably and are meant to include the first and second indicated numbers and all the fractional and integral numbers therebetween.
Unless otherwise indicated, numbers used herein and any number ranges based thereon are approximations within the accuracy of reasonable measurement and rounding errors as understood by persons skilled in the art.
It is appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention, which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable subcombination or as suitable in any other described embodiment of the invention. Certain features described in the context of various embodiments are not to be considered essential features of those embodiments, unless the embodiment is inoperative without those elements.
This application is a section 371 of International Application No. PCT/US16/068049, filed Dec. 21, 2016, which was published Feb. 8, 2018 under International Publication No. WO 2018/026385 A1, which claims the benefit of U.S. Provisional Application No. 62/369,505, filed Aug. 1, 2016, the contents of which are incorporated herein by their entirety.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2016/068049 | 12/21/2016 | WO |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2018/026385 | 2/8/2018 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
1795630 | Wilson | Mar 1931 | A |
2860635 | Wilburn | Nov 1958 | A |
3203269 | Perrine | Aug 1965 | A |
3212685 | James et al. | Oct 1965 | A |
3782365 | Pinna | Jan 1974 | A |
3794028 | Mueller et al. | Feb 1974 | A |
3946732 | Hurscham | Mar 1976 | A |
3994295 | Wulff | Nov 1976 | A |
4026128 | Blanco | May 1977 | A |
4167663 | Granzow et al. | Sep 1979 | A |
4195636 | Behnke | Apr 1980 | A |
4218724 | Kaufman | Aug 1980 | A |
4273122 | Whitney et al. | Jun 1981 | A |
4276879 | Yiournas | Jul 1981 | A |
4300554 | Hessberg et al. | Nov 1981 | A |
4396385 | Kelly et al. | Aug 1983 | A |
4403987 | Gottinger | Sep 1983 | A |
4435173 | Siposs et al. | Mar 1984 | A |
4465478 | Sabelman et al. | Aug 1984 | A |
4565543 | Bekkering et al. | Jan 1986 | A |
4585439 | Michel | Apr 1986 | A |
4599082 | Grimard | Jul 1986 | A |
4601702 | Hudson | Jul 1986 | A |
4634426 | Kamen | Jan 1987 | A |
4685903 | Cable et al. | Aug 1987 | A |
4689043 | Bisha | Aug 1987 | A |
4698055 | Sealfon | Oct 1987 | A |
4810215 | Kaneko | Mar 1989 | A |
4850966 | Grau et al. | Jul 1989 | A |
4867743 | Vaillancourt | Sep 1989 | A |
4886499 | Cirelli et al. | Dec 1989 | A |
4908014 | Kroyer | Mar 1990 | A |
4919596 | Slate et al. | Apr 1990 | A |
4929241 | Kulli | May 1990 | A |
4950235 | Slate et al. | Aug 1990 | A |
4950246 | Muller | Aug 1990 | A |
D322671 | Szwarc | Dec 1991 | S |
5090877 | D'Silva | Feb 1992 | A |
5109850 | Blanco et al. | May 1992 | A |
5112317 | Michel | May 1992 | A |
5131816 | Brown et al. | Jul 1992 | A |
5190521 | Hubbard et al. | Mar 1993 | A |
5254096 | Rondelet et al. | Oct 1993 | A |
5300045 | Plassche, Jr. | Apr 1994 | A |
5342313 | Campbell et al. | Aug 1994 | A |
5348544 | Sweeney et al. | Sep 1994 | A |
5354287 | Wacks | Oct 1994 | A |
5364364 | Kasvikis et al. | Nov 1994 | A |
5366498 | Brannan et al. | Nov 1994 | A |
5383865 | Michel | Jan 1995 | A |
5411482 | Campbell | May 1995 | A |
5445621 | Poli et al. | Aug 1995 | A |
5478315 | Brothers et al. | Dec 1995 | A |
5482446 | Williamson et al. | Jan 1996 | A |
5496274 | Graves et al. | Mar 1996 | A |
5501665 | Jhuboo et al. | Mar 1996 | A |
5505709 | Funderburk et al. | Apr 1996 | A |
D372098 | Lattin et al. | Jul 1996 | S |
5558639 | Gangemi et al. | Sep 1996 | A |
5562686 | Sauer et al. | Oct 1996 | A |
5593390 | Castellano et al. | Jan 1997 | A |
5616132 | Newman | Apr 1997 | A |
5643218 | Lynn et al. | Jul 1997 | A |
5645955 | Maglica | Jul 1997 | A |
5647853 | Feldmann et al. | Jul 1997 | A |
5658133 | Anderson et al. | Aug 1997 | A |
5662678 | Macklin | Sep 1997 | A |
5672160 | Oesterlind et al. | Sep 1997 | A |
D384745 | Lattin et al. | Oct 1997 | S |
5690618 | Smith et al. | Nov 1997 | A |
D393314 | Meisner et al. | Apr 1998 | S |
5766186 | Faraz et al. | Jun 1998 | A |
5779676 | Kriesel et al. | Jul 1998 | A |
5795675 | Maglica | Aug 1998 | A |
5800420 | Gross et al. | Sep 1998 | A |
5807375 | Gross et al. | Sep 1998 | A |
5814020 | Gross | Sep 1998 | A |
5820406 | Hetherington | Oct 1998 | A |
5830187 | Kriesel et al. | Nov 1998 | A |
5836920 | Robertson | Nov 1998 | A |
5848991 | Gross et al. | Dec 1998 | A |
5851197 | Marano et al. | Dec 1998 | A |
5858001 | Tsals et al. | Jan 1999 | A |
5858008 | Capaccio | Jan 1999 | A |
5868710 | Battiato et al. | Feb 1999 | A |
5931814 | Alex et al. | Aug 1999 | A |
5941850 | Shah et al. | Aug 1999 | A |
5948392 | Haslwanter et al. | Sep 1999 | A |
5954697 | Srisathapat et al. | Sep 1999 | A |
5957895 | Sage et al. | Sep 1999 | A |
5968011 | Larsen et al. | Oct 1999 | A |
5993423 | Choi | Nov 1999 | A |
5997501 | Gross et al. | Dec 1999 | A |
6004297 | Steenfeldt-Jensen et al. | Dec 1999 | A |
6033245 | Yamkovoy | Mar 2000 | A |
6033377 | Rasmussen et al. | Mar 2000 | A |
6064797 | Crittendon et al. | May 2000 | A |
6074369 | Sage et al. | Jun 2000 | A |
6117575 | Dinsdale | Sep 2000 | A |
6138865 | Gilmore | Oct 2000 | A |
6149614 | Dunshee et al. | Nov 2000 | A |
6160487 | DeLuca | Dec 2000 | A |
6175688 | Cassidy et al. | Jan 2001 | B1 |
6186982 | Gross et al. | Feb 2001 | B1 |
6200289 | Hochman et al. | Mar 2001 | B1 |
6200296 | Dibiasi et al. | Mar 2001 | B1 |
6224569 | Brimhall | May 2001 | B1 |
6248093 | Moberg | Jun 2001 | B1 |
6277095 | Kriesel et al. | Aug 2001 | B1 |
6277098 | Klitmose et al. | Aug 2001 | B1 |
6277099 | Strowe et al. | Aug 2001 | B1 |
6287283 | Ljunggreen et al. | Sep 2001 | B1 |
6293925 | Safabash et al. | Sep 2001 | B1 |
6302633 | Poe | Oct 2001 | B1 |
6305908 | Hermann et al. | Oct 2001 | B1 |
6336729 | Pavelle et al. | Jan 2002 | B1 |
6345968 | Shupe | Feb 2002 | B1 |
6362591 | Moberg | Mar 2002 | B1 |
6377848 | Garde et al. | Apr 2002 | B1 |
6391005 | Lum et al. | May 2002 | B1 |
6423029 | Elsberry | Jul 2002 | B1 |
6423035 | Das et al. | Jul 2002 | B1 |
6423036 | Van Huizen | Jul 2002 | B1 |
D465026 | May et al. | Oct 2002 | S |
6458102 | Mann et al. | Oct 2002 | B1 |
6485461 | Mason et al. | Nov 2002 | B1 |
6485465 | Moberg et al. | Nov 2002 | B2 |
6500150 | Gross et al. | Dec 2002 | B1 |
6503231 | Prausnitz et al. | Jan 2003 | B1 |
6511336 | Turek et al. | Jan 2003 | B1 |
6517517 | Farrugia et al. | Feb 2003 | B1 |
D471274 | Diaz et al. | Mar 2003 | S |
D471983 | Hippolyte et al. | Mar 2003 | S |
6530901 | Tsukada et al. | Mar 2003 | B1 |
6555986 | Moberg | Apr 2003 | B2 |
6558351 | Steil et al. | May 2003 | B1 |
6589229 | Connelly et al. | Jul 2003 | B1 |
6595205 | Andersson | Jul 2003 | B2 |
6595956 | Gross et al. | Jul 2003 | B1 |
6595960 | West et al. | Jul 2003 | B2 |
6599272 | Hjerlman et al. | Jul 2003 | B1 |
6632201 | Mathias et al. | Oct 2003 | B1 |
6645181 | Lavi et al. | Nov 2003 | B1 |
6652482 | Hochman | Nov 2003 | B2 |
6656158 | Mahoney et al. | Dec 2003 | B2 |
6656159 | Flaherty | Dec 2003 | B2 |
6659980 | Moberg et al. | Dec 2003 | B2 |
6673033 | Sciulli et al. | Jan 2004 | B1 |
6679862 | Diaz et al. | Jan 2004 | B2 |
6689118 | Alchas et al. | Feb 2004 | B2 |
6699218 | Flaherty et al. | Mar 2004 | B2 |
6722916 | Buccinna et al. | Apr 2004 | B2 |
6743211 | Prausnitz et al. | Jun 2004 | B1 |
6749587 | Flaherty | Jun 2004 | B2 |
6752787 | Causey et al. | Jun 2004 | B1 |
6768425 | Flaherty et al. | Jul 2004 | B2 |
6786890 | Preuthun et al. | Sep 2004 | B2 |
6800071 | Mcconnell et al. | Oct 2004 | B1 |
6805687 | Dextradeur et al. | Oct 2004 | B2 |
6824529 | Gross et al. | Nov 2004 | B2 |
6843782 | Gross et al. | Jan 2005 | B2 |
6854620 | Ramey | Feb 2005 | B2 |
6905298 | Haring | Jun 2005 | B1 |
6908452 | Diaz et al. | Jun 2005 | B2 |
6950028 | Zweig | Sep 2005 | B2 |
6960192 | Flaherty et al. | Nov 2005 | B1 |
6972002 | Thorne | Dec 2005 | B2 |
6997727 | Legrady et al. | Feb 2006 | B1 |
7001360 | Veasey et al. | Feb 2006 | B2 |
7034223 | Fan et al. | Apr 2006 | B2 |
7048715 | Diaz et al. | May 2006 | B2 |
7060054 | Nissels | Jun 2006 | B2 |
7060059 | Keith et al. | Jun 2006 | B2 |
7097637 | Triplett et al. | Aug 2006 | B2 |
7128727 | Flaherty et al. | Oct 2006 | B2 |
7144384 | Gorman et al. | Dec 2006 | B2 |
7193521 | Moberg et al. | Mar 2007 | B2 |
D544092 | Lewis | Jun 2007 | S |
7225694 | Said | Jun 2007 | B2 |
7247149 | Beyerlein | Jul 2007 | B2 |
7250037 | Shermer et al. | Jul 2007 | B2 |
7267669 | Staunton et al. | Sep 2007 | B2 |
7291132 | Deruntz et al. | Nov 2007 | B2 |
7291159 | Schmelzeisen-Redeker et al. | Nov 2007 | B2 |
7303549 | Flaherty et al. | Dec 2007 | B2 |
7344385 | Chen | Mar 2008 | B2 |
7364570 | Gerondale et al. | Apr 2008 | B2 |
7390314 | Stutz et al. | Jun 2008 | B2 |
7407493 | Cane | Aug 2008 | B2 |
D578210 | Muta et al. | Oct 2008 | S |
7455663 | Bikovsky | Nov 2008 | B2 |
7465290 | Reilly | Dec 2008 | B2 |
7488181 | Van | Feb 2009 | B2 |
7497842 | Diaz et al. | Mar 2009 | B2 |
7501587 | English | Mar 2009 | B2 |
7503786 | Kato et al. | Mar 2009 | B2 |
7524304 | Genosar | Apr 2009 | B2 |
7530964 | Lavi et al. | May 2009 | B2 |
7547281 | Hayes et al. | Jun 2009 | B2 |
7563253 | Tanner et al. | Jul 2009 | B2 |
7565208 | Harris et al. | Jul 2009 | B2 |
7569050 | Moberg et al. | Aug 2009 | B2 |
D600341 | Loerwald | Sep 2009 | S |
7585287 | Bresina et al. | Sep 2009 | B2 |
7588559 | Aravena et al. | Sep 2009 | B2 |
7589974 | Grady et al. | Sep 2009 | B2 |
D602155 | Foley et al. | Oct 2009 | S |
D602586 | Foley et al. | Oct 2009 | S |
D604835 | Conley | Nov 2009 | S |
7621893 | Moberg et al. | Nov 2009 | B2 |
7628770 | Ethelfeld | Dec 2009 | B2 |
7628772 | Mcconnell et al. | Dec 2009 | B2 |
7628782 | Mair et al. | Dec 2009 | B2 |
7637891 | Wall | Dec 2009 | B2 |
7637899 | Woolston et al. | Dec 2009 | B2 |
7641649 | Moberg et al. | Jan 2010 | B2 |
7660627 | Mcnichols et al. | Feb 2010 | B2 |
7678079 | Shermer et al. | Mar 2010 | B2 |
7682338 | Griffin | Mar 2010 | B2 |
7686787 | Moberg et al. | Mar 2010 | B2 |
7699829 | Harris et al. | Apr 2010 | B2 |
7699833 | Moberg et al. | Apr 2010 | B2 |
7704088 | Sakamoto | Apr 2010 | B2 |
7704227 | Moberg et al. | Apr 2010 | B2 |
7704229 | Moberg et al. | Apr 2010 | B2 |
7704231 | Pongpairochana et al. | Apr 2010 | B2 |
7708717 | Estes et al. | May 2010 | B2 |
7713238 | Mernoe | May 2010 | B2 |
7713240 | Istoc et al. | May 2010 | B2 |
7717913 | Novak et al. | May 2010 | B2 |
7722574 | Toman et al. | May 2010 | B2 |
7736344 | Moberg et al. | Jun 2010 | B2 |
7744589 | Mounce et al. | Jun 2010 | B2 |
7749194 | Edwards et al. | Jul 2010 | B2 |
7753879 | Mernoe | Jul 2010 | B2 |
7766873 | Moberg et al. | Aug 2010 | B2 |
7776030 | Estes et al. | Aug 2010 | B2 |
7780636 | Radmer et al. | Aug 2010 | B2 |
7780637 | Jerde et al. | Aug 2010 | B2 |
7789857 | Moberg et al. | Sep 2010 | B2 |
7789862 | Thorne, Jr. | Sep 2010 | B2 |
7801599 | Young et al. | Sep 2010 | B2 |
7806868 | De Polo et al. | Oct 2010 | B2 |
7815622 | Istoc et al. | Oct 2010 | B2 |
7828528 | Estes et al. | Nov 2010 | B2 |
7837659 | Bush et al. | Nov 2010 | B2 |
7846132 | Gravesen et al. | Dec 2010 | B2 |
7854723 | Hwang et al. | Dec 2010 | B2 |
7857131 | Vedrine | Dec 2010 | B2 |
7879025 | Jacobson et al. | Feb 2011 | B2 |
7879026 | Estes et al. | Feb 2011 | B2 |
7892206 | Moberg et al. | Feb 2011 | B2 |
7918825 | O'Connor et al. | Apr 2011 | B2 |
7918843 | Genosar et al. | Apr 2011 | B2 |
7935104 | Yodat et al. | May 2011 | B2 |
7935105 | Miller et al. | May 2011 | B2 |
7938803 | Mernoe et al. | May 2011 | B2 |
7955305 | Moberg et al. | Jun 2011 | B2 |
7967784 | Pongpairochana et al. | Jun 2011 | B2 |
7967795 | Cabiri | Jun 2011 | B1 |
7981105 | Adair et al. | Jul 2011 | B2 |
7988683 | Adair et al. | Aug 2011 | B2 |
7993300 | Nyholm et al. | Aug 2011 | B2 |
7993301 | Boyd et al. | Aug 2011 | B2 |
7998111 | Moberg et al. | Aug 2011 | B2 |
8021357 | Tanaka et al. | Sep 2011 | B2 |
8025658 | Chong et al. | Sep 2011 | B2 |
8029469 | Ethelfeld | Oct 2011 | B2 |
8034019 | Nair et al. | Oct 2011 | B2 |
8038666 | Triplett et al. | Oct 2011 | B2 |
8057431 | Woehr et al. | Nov 2011 | B2 |
8057436 | Causey et al. | Nov 2011 | B2 |
8062253 | Nielsen et al. | Nov 2011 | B2 |
8062257 | Moberg et al. | Nov 2011 | B2 |
8065096 | Moberg et al. | Nov 2011 | B2 |
8066694 | Wagener | Nov 2011 | B2 |
D650079 | Presta et al. | Dec 2011 | S |
D650903 | Kosinski et al. | Dec 2011 | S |
8086306 | Katzman et al. | Dec 2011 | B2 |
D652503 | Cameron et al. | Jan 2012 | S |
8105279 | Mernoe et al. | Jan 2012 | B2 |
8114046 | Covino et al. | Feb 2012 | B2 |
8114064 | Alferness et al. | Feb 2012 | B2 |
8114066 | Naef et al. | Feb 2012 | B2 |
D657462 | Siroky | Apr 2012 | S |
8147446 | Yodat et al. | Apr 2012 | B2 |
8152764 | Istoc et al. | Apr 2012 | B2 |
8152770 | Reid | Apr 2012 | B2 |
8152779 | Cabiri | Apr 2012 | B2 |
8152793 | Keinaenen et al. | Apr 2012 | B2 |
8157693 | Waksmundzki | Apr 2012 | B2 |
8157769 | Cabiri | Apr 2012 | B2 |
8162674 | Cho et al. | Apr 2012 | B2 |
8162923 | Adams et al. | Apr 2012 | B2 |
8167841 | Teisen-Simony et al. | May 2012 | B2 |
8172591 | Wertz | May 2012 | B2 |
8172804 | Bikovsky | May 2012 | B2 |
8182447 | Moberg et al. | May 2012 | B2 |
8182462 | Istoc et al. | May 2012 | B2 |
8197444 | Bazargan et al. | Jun 2012 | B1 |
8206351 | Sugimoto et al. | Jun 2012 | B2 |
8221356 | Enggaard et al. | Jul 2012 | B2 |
8267893 | Moberg et al. | Sep 2012 | B2 |
8267921 | Yodat et al. | Sep 2012 | B2 |
8287520 | Drew et al. | Oct 2012 | B2 |
8292647 | Mcgrath et al. | Oct 2012 | B1 |
8308679 | Hanson et al. | Nov 2012 | B2 |
8323250 | Chong et al. | Dec 2012 | B2 |
8348898 | Cabiri | Jan 2013 | B2 |
8372039 | Mernoe et al. | Feb 2013 | B2 |
8373421 | Lindegger et al. | Feb 2013 | B2 |
8409142 | Causey et al. | Apr 2013 | B2 |
8414557 | Istoc et al. | Apr 2013 | B2 |
8430847 | Mernoe et al. | Apr 2013 | B2 |
D685083 | Schneider et al. | Jun 2013 | S |
8465455 | Cabiri | Jun 2013 | B2 |
8469942 | Kow et al. | Jun 2013 | B2 |
D687141 | Schneider et al. | Jul 2013 | S |
8474332 | Bente et al. | Jul 2013 | B2 |
8475408 | Mernoe et al. | Jul 2013 | B2 |
8479595 | Vazquez et al. | Jul 2013 | B2 |
8483980 | Moberg et al. | Jul 2013 | B2 |
8495918 | Bazargan et al. | Jul 2013 | B2 |
8496862 | Zelkovich et al. | Jul 2013 | B2 |
D687536 | Guarraia et al. | Aug 2013 | S |
8512287 | Cindrich et al. | Aug 2013 | B2 |
8517987 | Istoc et al. | Aug 2013 | B2 |
8523803 | Favreau | Sep 2013 | B1 |
D692552 | Lovell et al. | Oct 2013 | S |
8556856 | Bazargan et al. | Oct 2013 | B2 |
8562364 | Lin et al. | Oct 2013 | B2 |
8574216 | Istoc et al. | Nov 2013 | B2 |
8603026 | Favreau | Dec 2013 | B2 |
8603027 | Favreau | Dec 2013 | B2 |
8617110 | Moberg et al. | Dec 2013 | B2 |
8628510 | Bazargan et al. | Jan 2014 | B2 |
8647074 | Moberg et al. | Feb 2014 | B2 |
8647296 | Moberg et al. | Feb 2014 | B2 |
8668672 | Moberg et al. | Mar 2014 | B2 |
8674288 | Hanson et al. | Mar 2014 | B2 |
8679060 | Mernoe et al. | Mar 2014 | B2 |
8681010 | Moberg et al. | Mar 2014 | B2 |
8690855 | Alderete et al. | Apr 2014 | B2 |
8708961 | Field et al. | Apr 2014 | B2 |
8751237 | Kubota | Jun 2014 | B2 |
8753326 | Chong et al. | Jun 2014 | B2 |
8753331 | Murphy | Jun 2014 | B2 |
8764707 | Moberg et al. | Jul 2014 | B2 |
8764723 | Chong et al. | Jul 2014 | B2 |
8771222 | Kanderian et al. | Jul 2014 | B2 |
8777896 | Starkweather et al. | Jul 2014 | B2 |
8777924 | Kanderian et al. | Jul 2014 | B2 |
8777925 | Patton | Jul 2014 | B2 |
8784369 | Starkweather et al. | Jul 2014 | B2 |
8784370 | Lebel et al. | Jul 2014 | B2 |
8790295 | Sigg et al. | Jul 2014 | B1 |
8795224 | Starkweather et al. | Aug 2014 | B2 |
8795231 | Chong et al. | Aug 2014 | B2 |
8795260 | Drew | Aug 2014 | B2 |
8801668 | Ali et al. | Aug 2014 | B2 |
8801679 | Iio et al. | Aug 2014 | B2 |
8810394 | Kalpin | Aug 2014 | B2 |
8814379 | Griffiths et al. | Aug 2014 | B2 |
8915882 | Cabiri | Dec 2014 | B2 |
8920374 | Bokelman et al. | Dec 2014 | B2 |
D723157 | Clemente et al. | Feb 2015 | S |
9061104 | Daniel | Jun 2015 | B2 |
9061110 | Avery et al. | Jun 2015 | B2 |
9072827 | Cabiri | Jul 2015 | B2 |
9089475 | Fangrow | Jul 2015 | B2 |
9089641 | Kavazov | Jul 2015 | B2 |
9149575 | Cabiri | Oct 2015 | B2 |
9393365 | Cabiri | Jul 2016 | B2 |
D768288 | O'Connor et al. | Oct 2016 | S |
9463280 | Cabiri | Oct 2016 | B2 |
9492610 | Cabiri | Nov 2016 | B2 |
D774640 | Tyce et al. | Dec 2016 | S |
9511190 | Cabiri | Dec 2016 | B2 |
9522234 | Cabiri | Dec 2016 | B2 |
D776262 | Tyce et al. | Jan 2017 | S |
D776263 | Tyce et al. | Jan 2017 | S |
D776264 | Tyce et al. | Jan 2017 | S |
D776265 | Tyce et al. | Jan 2017 | S |
9572926 | Cabiri | Feb 2017 | B2 |
9707335 | Agard et al. | Jul 2017 | B2 |
D794776 | Tyce et al. | Aug 2017 | S |
9737655 | Clemente et al. | Aug 2017 | B2 |
9782545 | Gross et al. | Oct 2017 | B2 |
9802030 | Clemente et al. | Oct 2017 | B2 |
D804019 | Costello et al. | Nov 2017 | S |
9814832 | Agard et al. | Nov 2017 | B2 |
D804650 | Costello et al. | Dec 2017 | S |
D805186 | Costello et al. | Dec 2017 | S |
D805187 | Costello et al. | Dec 2017 | S |
D805188 | Costello et al. | Dec 2017 | S |
D805189 | Costello et al. | Dec 2017 | S |
D805190 | Costello et al. | Dec 2017 | S |
9861759 | Gross et al. | Jan 2018 | B2 |
D810278 | Cabiri et al. | Feb 2018 | S |
D810279 | Cabiri et al. | Feb 2018 | S |
D811583 | Cabiri et al. | Feb 2018 | S |
D811584 | Cabiri et al. | Feb 2018 | S |
D817481 | Cabiri et al. | May 2018 | S |
D851752 | Nazzaro et al. | Jun 2019 | S |
D865945 | Nazzaro et al. | Nov 2019 | S |
20010025168 | Gross et al. | Sep 2001 | A1 |
20010041869 | Causey et al. | Nov 2001 | A1 |
20020010423 | Gross et al. | Jan 2002 | A1 |
20020029018 | Jeffrey | Mar 2002 | A1 |
20020040208 | Flaherty et al. | Apr 2002 | A1 |
20020043951 | Moberg | Apr 2002 | A1 |
20020055711 | Lavi et al. | May 2002 | A1 |
20020065488 | Suzuki et al. | May 2002 | A1 |
20020100472 | Casper | Aug 2002 | A1 |
20020107487 | Preuthun | Aug 2002 | A1 |
20020123740 | Flaherty et al. | Sep 2002 | A1 |
20020161332 | Ramey | Oct 2002 | A1 |
20020169215 | Meng | Nov 2002 | A1 |
20030009133 | Ramey | Jan 2003 | A1 |
20030109827 | Lavi et al. | Jun 2003 | A1 |
20030125671 | Aramata et al. | Jul 2003 | A1 |
20030135159 | Daily et al. | Jul 2003 | A1 |
20030160683 | Blomquist | Aug 2003 | A1 |
20030171717 | Farrugia et al. | Sep 2003 | A1 |
20030181868 | Swenson | Sep 2003 | A1 |
20030199825 | Flaherty | Oct 2003 | A1 |
20030199827 | Thorne | Oct 2003 | A1 |
20030236498 | Gross et al. | Dec 2003 | A1 |
20040010207 | Flaherty et al. | Jan 2004 | A1 |
20040015131 | Flaherty et al. | Jan 2004 | A1 |
20040064088 | Gorman et al. | Apr 2004 | A1 |
20040085215 | Moberg et al. | May 2004 | A1 |
20040092873 | Moberg | May 2004 | A1 |
20040116866 | Gorman et al. | Jun 2004 | A1 |
20040127857 | Shemesh et al. | Jul 2004 | A1 |
20040158172 | Hancock | Aug 2004 | A1 |
20040186419 | Cho | Sep 2004 | A1 |
20040186424 | Hjertman | Sep 2004 | A1 |
20040260233 | Garibotto et al. | Dec 2004 | A1 |
20050033234 | Sadowski et al. | Feb 2005 | A1 |
20050049553 | Triplett et al. | Mar 2005 | A1 |
20050065466 | Vedrine | Mar 2005 | A1 |
20050065472 | Cindrich et al. | Mar 2005 | A1 |
20050070845 | Faries et al. | Mar 2005 | A1 |
20050071487 | Lu et al. | Mar 2005 | A1 |
20050113761 | Faust et al. | May 2005 | A1 |
20050159706 | Wilkinson et al. | Jul 2005 | A1 |
20050171476 | Judson et al. | Aug 2005 | A1 |
20050171512 | Flaherty | Aug 2005 | A1 |
20050177136 | Miller | Aug 2005 | A1 |
20050197650 | Sugimoto et al. | Sep 2005 | A1 |
20050203461 | Flaherty et al. | Sep 2005 | A1 |
20050238507 | Diianni et al. | Oct 2005 | A1 |
20050283114 | Bresina et al. | Dec 2005 | A1 |
20060013716 | Nason et al. | Jan 2006 | A1 |
20060030816 | Zubry | Feb 2006 | A1 |
20060095014 | Ethelfeld | May 2006 | A1 |
20060122577 | Poulsen et al. | Jun 2006 | A1 |
20060173406 | Hayes et al. | Aug 2006 | A1 |
20060173408 | Wyrick | Aug 2006 | A1 |
20060173410 | Moberg et al. | Aug 2006 | A1 |
20060173439 | Thorne et al. | Aug 2006 | A1 |
20060184154 | Moberg et al. | Aug 2006 | A1 |
20060195029 | Shults et al. | Aug 2006 | A1 |
20060211982 | Prestrelski et al. | Sep 2006 | A1 |
20060229569 | Lavi et al. | Oct 2006 | A1 |
20060264831 | Skwarek et al. | Nov 2006 | A1 |
20060264889 | Moberg et al. | Nov 2006 | A1 |
20060264890 | Moberg et al. | Nov 2006 | A1 |
20060264894 | Moberg et al. | Nov 2006 | A1 |
20060270987 | Peter | Nov 2006 | A1 |
20060283465 | Nickel et al. | Dec 2006 | A1 |
20060293722 | Slatkine et al. | Dec 2006 | A1 |
20070016381 | Kamath et al. | Jan 2007 | A1 |
20070021733 | Hansen et al. | Jan 2007 | A1 |
20070049865 | Radmer et al. | Mar 2007 | A1 |
20070073228 | Mernoe et al. | Mar 2007 | A1 |
20070106218 | Yodfat et al. | May 2007 | A1 |
20070118405 | Campbell et al. | May 2007 | A1 |
20070123819 | Mernoe et al. | May 2007 | A1 |
20070129688 | Scheurer et al. | Jun 2007 | A1 |
20070149926 | Moberg et al. | Jun 2007 | A1 |
20070167912 | Causey et al. | Jul 2007 | A1 |
20070185449 | Mernoe | Aug 2007 | A1 |
20070191770 | Moberg et al. | Aug 2007 | A1 |
20070197968 | Pongpairochana et al. | Aug 2007 | A1 |
20070203454 | Shermer et al. | Aug 2007 | A1 |
20070219480 | Kamen et al. | Sep 2007 | A1 |
20070233038 | Pruitt et al. | Oct 2007 | A1 |
20070282269 | Carter et al. | Dec 2007 | A1 |
20080021439 | Brittingham et al. | Jan 2008 | A1 |
20080033367 | Haury et al. | Feb 2008 | A1 |
20080033369 | Kohlbrenner et al. | Feb 2008 | A1 |
20080033393 | Edwards et al. | Feb 2008 | A1 |
20080051710 | Moberg et al. | Feb 2008 | A1 |
20080051711 | Mounce et al. | Feb 2008 | A1 |
20080051727 | Moberg et al. | Feb 2008 | A1 |
20080051730 | Bikovsky | Feb 2008 | A1 |
20080059133 | Edwards et al. | Mar 2008 | A1 |
20080097381 | Moberg et al. | Apr 2008 | A1 |
20080099015 | Pocock | May 2008 | A1 |
20080108951 | Jerde et al. | May 2008 | A1 |
20080125700 | Moberg et al. | May 2008 | A1 |
20080140006 | Eskuri et al. | Jun 2008 | A1 |
20080140018 | Enggaard et al. | Jun 2008 | A1 |
20080147004 | Mann et al. | Jun 2008 | A1 |
20080156476 | Smisson et al. | Jul 2008 | A1 |
20080167641 | Hansen et al. | Jul 2008 | A1 |
20080188813 | Miller et al. | Aug 2008 | A1 |
20080195049 | Thalmann et al. | Aug 2008 | A1 |
20080208138 | Lim et al. | Aug 2008 | A1 |
20080215006 | Thorkild | Sep 2008 | A1 |
20080215015 | Cindrich et al. | Sep 2008 | A1 |
20080221522 | Moberg et al. | Sep 2008 | A1 |
20080221523 | Moberg et al. | Sep 2008 | A1 |
20080234627 | Dent et al. | Sep 2008 | A1 |
20080243087 | Enggaard et al. | Oct 2008 | A1 |
20080249473 | Rutti et al. | Oct 2008 | A1 |
20080255516 | Yodfat et al. | Oct 2008 | A1 |
20080262436 | Olson | Oct 2008 | A1 |
20080269687 | Chong et al. | Oct 2008 | A1 |
20080269723 | Mastrototaro et al. | Oct 2008 | A1 |
20080274630 | Shelton et al. | Nov 2008 | A1 |
20080275407 | Scheurer | Nov 2008 | A1 |
20080281270 | Cross et al. | Nov 2008 | A1 |
20080294143 | Tanaka et al. | Nov 2008 | A1 |
20080306449 | Kristensen et al. | Dec 2008 | A1 |
20080312601 | Cane | Dec 2008 | A1 |
20080319416 | Yodat et al. | Dec 2008 | A1 |
20090041805 | Walker | Feb 2009 | A1 |
20090043253 | Podaima | Feb 2009 | A1 |
20090048347 | Cohen et al. | Feb 2009 | A1 |
20090054750 | Jennewine | Feb 2009 | A1 |
20090054852 | Takano et al. | Feb 2009 | A1 |
20090062767 | Van et al. | Mar 2009 | A1 |
20090069784 | Estes et al. | Mar 2009 | A1 |
20090076360 | Brister et al. | Mar 2009 | A1 |
20090076453 | Mejlhede et al. | Mar 2009 | A1 |
20090088694 | Carter et al. | Apr 2009 | A1 |
20090088731 | Campbell et al. | Apr 2009 | A1 |
20090093792 | Gross et al. | Apr 2009 | A1 |
20090093793 | Gross et al. | Apr 2009 | A1 |
20090105650 | Wiegel et al. | Apr 2009 | A1 |
20090124977 | Jensen | May 2009 | A1 |
20090131860 | Nielsen | May 2009 | A1 |
20090139724 | Gray et al. | Jun 2009 | A1 |
20090143730 | De et al. | Jun 2009 | A1 |
20090143735 | De Polo et al. | Jun 2009 | A1 |
20090149830 | Spector | Jun 2009 | A1 |
20090182277 | Carter | Jul 2009 | A1 |
20090204076 | Liversidge | Aug 2009 | A1 |
20090209896 | Selevan | Aug 2009 | A1 |
20090216103 | Brister et al. | Aug 2009 | A1 |
20090234319 | Marksteiner | Sep 2009 | A1 |
20090240240 | Hines et al. | Sep 2009 | A1 |
20090243234 | Sharif | Oct 2009 | A1 |
20090253973 | Bashan et al. | Oct 2009 | A1 |
20090259176 | Yairi | Oct 2009 | A1 |
20090281585 | Katzman et al. | Nov 2009 | A1 |
20090299290 | Moberg | Dec 2009 | A1 |
20090299397 | Ruan et al. | Dec 2009 | A1 |
20090326459 | Shipway et al. | Dec 2009 | A1 |
20090326509 | Muse et al. | Dec 2009 | A1 |
20100030156 | Beebe et al. | Feb 2010 | A1 |
20100030198 | Beebe et al. | Feb 2010 | A1 |
20100037680 | Moberg et al. | Feb 2010 | A1 |
20100044270 | Noble | Feb 2010 | A1 |
20100049128 | Mckenzie et al. | Feb 2010 | A1 |
20100049144 | Mcconnell et al. | Feb 2010 | A1 |
20100057057 | Hayter et al. | Mar 2010 | A1 |
20100076412 | Rush et al. | Mar 2010 | A1 |
20100081993 | O'Connor | Apr 2010 | A1 |
20100094255 | Nycz et al. | Apr 2010 | A1 |
20100100076 | Rush et al. | Apr 2010 | A1 |
20100100077 | Rush et al. | Apr 2010 | A1 |
20100106098 | Atterbury et al. | Apr 2010 | A1 |
20100121314 | Iobbi | May 2010 | A1 |
20100137790 | Yodfat | Jun 2010 | A1 |
20100137831 | Tsais | Jun 2010 | A1 |
20100145303 | Yodfat et al. | Jun 2010 | A1 |
20100145305 | Alon | Jun 2010 | A1 |
20100152658 | Hanson et al. | Jun 2010 | A1 |
20100162548 | Leidig | Jul 2010 | A1 |
20100168607 | Miesel | Jul 2010 | A1 |
20100168683 | Cabiri | Jul 2010 | A1 |
20100198157 | Gyrn et al. | Aug 2010 | A1 |
20100204657 | Yodfat et al. | Aug 2010 | A1 |
20100211011 | Haar | Aug 2010 | A1 |
20100217192 | Moberg et al. | Aug 2010 | A1 |
20100217193 | Moberg et al. | Aug 2010 | A1 |
20100234767 | Sarstedt | Sep 2010 | A1 |
20100234805 | Kaufmann et al. | Sep 2010 | A1 |
20100234830 | Straessler et al. | Sep 2010 | A1 |
20100241065 | Moberg et al. | Sep 2010 | A1 |
20100264931 | Lindegger et al. | Oct 2010 | A1 |
20100274112 | Hoss et al. | Oct 2010 | A1 |
20100274192 | Mernoe | Oct 2010 | A1 |
20100274202 | Hyde et al. | Oct 2010 | A1 |
20100276411 | Hansen et al. | Nov 2010 | A1 |
20100280499 | Yodfat et al. | Nov 2010 | A1 |
20100331826 | Field et al. | Dec 2010 | A1 |
20110034900 | Yodfat et al. | Feb 2011 | A1 |
20110054399 | Chong et al. | Mar 2011 | A1 |
20110054400 | Chong et al. | Mar 2011 | A1 |
20110060284 | Harr | Mar 2011 | A1 |
20110066131 | Cabiri | Mar 2011 | A1 |
20110119033 | Moberg et al. | May 2011 | A1 |
20110125056 | Merchant | May 2011 | A1 |
20110137239 | DeBelser et al. | Jun 2011 | A1 |
20110144584 | Wozencroft | Jun 2011 | A1 |
20110160654 | Hanson et al. | Jun 2011 | A1 |
20110160655 | Hanson et al. | Jun 2011 | A1 |
20110160666 | Hanson et al. | Jun 2011 | A1 |
20110160669 | Gyrn et al. | Jun 2011 | A1 |
20110172645 | Moga et al. | Jul 2011 | A1 |
20110172745 | Na et al. | Jul 2011 | A1 |
20110178463 | Cabiri | Jul 2011 | A1 |
20110178472 | Cabiri | Jul 2011 | A1 |
20110184342 | Pesach et al. | Jul 2011 | A1 |
20110201998 | Pongpairochana et al. | Aug 2011 | A1 |
20110224614 | Moberg et al. | Sep 2011 | A1 |
20110238031 | Mair et al. | Sep 2011 | A1 |
20110245773 | Estes et al. | Oct 2011 | A1 |
20110264383 | Moberg et al. | Oct 2011 | A1 |
20110270160 | Mernoe | Nov 2011 | A1 |
20110282282 | Lorenzen et al. | Nov 2011 | A1 |
20110282296 | Harms et al. | Nov 2011 | A1 |
20110295205 | Kaufmann et al. | Dec 2011 | A1 |
20110313238 | Reichenbach et al. | Dec 2011 | A1 |
20110313351 | Kamen et al. | Dec 2011 | A1 |
20110319861 | Wilk | Dec 2011 | A1 |
20110319919 | Curry et al. | Dec 2011 | A1 |
20120004602 | Hanson et al. | Jan 2012 | A1 |
20120010594 | Holt et al. | Jan 2012 | A1 |
20120022344 | Kube | Jan 2012 | A1 |
20120022499 | Anderson et al. | Jan 2012 | A1 |
20120025995 | Moberg et al. | Feb 2012 | A1 |
20120029431 | Hwang et al. | Feb 2012 | A1 |
20120035546 | Cabiri | Feb 2012 | A1 |
20120041364 | Smith | Feb 2012 | A1 |
20120041370 | Moberg et al. | Feb 2012 | A1 |
20120041414 | Estes et al. | Feb 2012 | A1 |
20120059332 | Woehr et al. | Mar 2012 | A1 |
20120071819 | Brueggemann et al. | Mar 2012 | A1 |
20120071828 | Tojo et al. | Mar 2012 | A1 |
20120096953 | Bente et al. | Apr 2012 | A1 |
20120096954 | Vazquez et al. | Apr 2012 | A1 |
20120101436 | Bazargan et al. | Apr 2012 | A1 |
20120108933 | Liang et al. | May 2012 | A1 |
20120129362 | Hampo et al. | May 2012 | A1 |
20120132203 | Hodson | May 2012 | A1 |
20120160033 | Kow et al. | Jun 2012 | A1 |
20120165733 | Bazargan et al. | Jun 2012 | A1 |
20120165780 | Bazargan et al. | Jun 2012 | A1 |
20120215169 | Moberg et al. | Aug 2012 | A1 |
20120215199 | Moberg et al. | Aug 2012 | A1 |
20120226234 | Bazargan et al. | Sep 2012 | A1 |
20120259282 | Alderete et al. | Oct 2012 | A1 |
20120310153 | Moberg et al. | Dec 2012 | A1 |
20130012875 | Gross et al. | Jan 2013 | A1 |
20130060233 | O'Connor et al. | Mar 2013 | A1 |
20130068319 | Plumptre et al. | Mar 2013 | A1 |
20130085457 | Schiff et al. | Apr 2013 | A1 |
20130089992 | Yang | Apr 2013 | A1 |
20130096509 | Avery et al. | Apr 2013 | A1 |
20130110049 | Cronenberg et al. | May 2013 | A1 |
20130133438 | Kow et al. | May 2013 | A1 |
20130175192 | Iio et al. | Jul 2013 | A1 |
20130218089 | Davies et al. | Aug 2013 | A1 |
20130218092 | Davies et al. | Aug 2013 | A1 |
20130237953 | Kow et al. | Sep 2013 | A1 |
20130245595 | Kow et al. | Sep 2013 | A1 |
20130245596 | Cabiri et al. | Sep 2013 | A1 |
20130253419 | Favreau | Sep 2013 | A1 |
20130253420 | Favreau | Sep 2013 | A1 |
20130253421 | Favreau | Sep 2013 | A1 |
20130253472 | Cabiri | Sep 2013 | A1 |
20130296792 | Cabiri | Nov 2013 | A1 |
20130296799 | Degtiar et al. | Nov 2013 | A1 |
20130304021 | Cabiri et al. | Nov 2013 | A1 |
20130310753 | Cabiri | Nov 2013 | A1 |
20130323699 | Edwards et al. | Dec 2013 | A1 |
20130331791 | Gross et al. | Dec 2013 | A1 |
20140012229 | Bokelman | Jan 2014 | A1 |
20140055073 | Favreau | Feb 2014 | A1 |
20140055076 | Favreau | Feb 2014 | A1 |
20140058349 | Bazargan et al. | Feb 2014 | A1 |
20140083517 | Moia et al. | Mar 2014 | A1 |
20140094755 | Bazargan et al. | Apr 2014 | A1 |
20140128807 | Moberg et al. | May 2014 | A1 |
20140128815 | Cabiri et al. | May 2014 | A1 |
20140128835 | Moberg et al. | May 2014 | A1 |
20140135692 | Alderete et al. | May 2014 | A1 |
20140135694 | Moberg et al. | May 2014 | A1 |
20140142499 | Moberg et al. | May 2014 | A1 |
20140148784 | Anderson et al. | May 2014 | A1 |
20140148785 | Moberg et al. | May 2014 | A1 |
20140163522 | Alderete et al. | Jun 2014 | A1 |
20140171881 | Cabiri | Jun 2014 | A1 |
20140188073 | Cabiri et al. | Jul 2014 | A1 |
20140194819 | Maule et al. | Jul 2014 | A1 |
20140194854 | Tsais | Jul 2014 | A1 |
20140207064 | Yavorsky | Jul 2014 | A1 |
20140207065 | Yavorsky | Jul 2014 | A1 |
20140207066 | Yavorsky | Jul 2014 | A1 |
20140210631 | Zavis | Jul 2014 | A1 |
20140213975 | Clemente et al. | Jul 2014 | A1 |
20140236087 | Alderete et al. | Aug 2014 | A1 |
20140261758 | Wlodarczyk et al. | Sep 2014 | A1 |
20140288511 | Tan-Malecki et al. | Sep 2014 | A1 |
20140330240 | Cabiri et al. | Nov 2014 | A1 |
20150011965 | Cabiri | Jan 2015 | A1 |
20150011976 | Vouillamoz et al. | Jan 2015 | A1 |
20150032084 | Cabiri | Jan 2015 | A1 |
20150057613 | Clemente et al. | Feb 2015 | A1 |
20150119797 | Cabiri | Apr 2015 | A1 |
20150174346 | Dhuppad | Jun 2015 | A1 |
20150224253 | Cabiri | Aug 2015 | A1 |
20150297833 | Henderson | Oct 2015 | A1 |
20150367074 | Draper | Dec 2015 | A1 |
20160015910 | Mukai et al. | Jan 2016 | A1 |
20160058941 | Wu et al. | Mar 2016 | A1 |
20160199592 | Eggert et al. | Jul 2016 | A1 |
20160228644 | Cabiri | Aug 2016 | A1 |
20160256352 | Bar-El et al. | Sep 2016 | A1 |
20170028132 | Cronenberg et al. | Feb 2017 | A1 |
20170106138 | Cabiri | Apr 2017 | A1 |
20170224915 | Destefano et al. | Aug 2017 | A1 |
20170281859 | Agard et al. | Oct 2017 | A1 |
20170312450 | Gross et al. | Nov 2017 | A1 |
20170354781 | Cronenberg et al. | Dec 2017 | A1 |
20170354782 | Quinn et al. | Dec 2017 | A1 |
20170354783 | Gazeley et al. | Dec 2017 | A1 |
20170354785 | Gazeley et al. | Dec 2017 | A1 |
20170354788 | Quinn et al. | Dec 2017 | A1 |
20180001073 | Clemente et al. | Jan 2018 | A1 |
20180008769 | O'Connor et al. | Jan 2018 | A1 |
20180021508 | Destefano et al. | Jan 2018 | A1 |
20180028747 | Hanson et al. | Feb 2018 | A1 |
20180043091 | Agard et al. | Feb 2018 | A1 |
20180055995 | Hanson et al. | Mar 2018 | A1 |
20180221584 | Grimoldby | Aug 2018 | A1 |
20180236173 | Mccaffrey et al. | Aug 2018 | A1 |
20190091404 | Nazzaro et al. | Mar 2019 | A1 |
20190117880 | Hirschel et al. | Apr 2019 | A1 |
20190366012 | Gross et al. | Dec 2019 | A1 |
20200282144 | Pearson | Sep 2020 | A1 |
Number | Date | Country |
---|---|---|
1224341 | Jul 1999 | CN |
1408443 | Apr 2003 | CN |
1636605 | Jul 2005 | CN |
1747683 | Mar 2006 | CN |
1863566 | Nov 2006 | CN |
1929884 | Mar 2007 | CN |
101001661 | Jul 2007 | CN |
101090749 | Dec 2007 | CN |
101239205 | Aug 2008 | CN |
101460207 | Jun 2009 | CN |
101687083 | Mar 2010 | CN |
101868273 | Oct 2010 | CN |
101970033 | Feb 2011 | CN |
201941304 | Aug 2011 | CN |
102186733 | Sep 2011 | CN |
102256657 | Nov 2011 | CN |
102639169 | Aug 2012 | CN |
104703641 | Jun 2015 | CN |
104955504 | Sep 2015 | CN |
1064693 | Sep 1959 | DE |
0017412 | Oct 1980 | EP |
0222656 | May 1987 | EP |
0401179 | Dec 1990 | EP |
0744975 | Dec 1996 | EP |
1530979 | May 2005 | EP |
1666080 | Jun 2006 | EP |
2060606 | May 2009 | EP |
2345441 | Jul 2011 | EP |
2498589 | Sep 2012 | EP |
2698180 | Feb 2014 | EP |
2727617 | May 2014 | EP |
2454483 | Aug 2015 | EP |
07-194701 | Aug 1995 | JP |
09-505758 | Jun 1997 | JP |
1224341 | Jul 1999 | JP |
2001-512992 | Aug 2001 | JP |
2002-505601 | Feb 2002 | JP |
2002-507459 | Mar 2002 | JP |
2002-528676 | Sep 2002 | JP |
2003-501157 | Jan 2003 | JP |
2003-534061 | Nov 2003 | JP |
2004-501721 | Jan 2004 | JP |
2004-512100 | Apr 2004 | JP |
2003-527138 | Aug 2005 | JP |
2005-523127 | Aug 2005 | JP |
2005-270629 | Oct 2005 | JP |
2007-509661 | Apr 2007 | JP |
2008100762 | May 2008 | JP |
2008-534131 | Aug 2008 | JP |
2008-220961 | Sep 2008 | JP |
2009-502273 | Jan 2009 | JP |
2015524722 | Aug 2015 | JP |
2015536715 | Dec 2015 | JP |
8911302 | Nov 1989 | WO |
9009202 | Aug 1990 | WO |
9307922 | Apr 1993 | WO |
9407553 | Apr 1994 | WO |
9513838 | May 1995 | WO |
9521645 | Aug 1995 | WO |
9609083 | Mar 1996 | WO |
9632975 | Oct 1996 | WO |
9700091 | Jan 1997 | WO |
9710012 | Mar 1997 | WO |
9721457 | Jun 1997 | WO |
9733638 | Sep 1997 | WO |
9857683 | Dec 1998 | WO |
9929151 | Jun 1999 | WO |
9959665 | Nov 1999 | WO |
0025844 | May 2000 | WO |
0187384 | Nov 2001 | WO |
0189607 | Nov 2001 | WO |
0189613 | Nov 2001 | WO |
0202165 | Jan 2002 | WO |
0234315 | May 2002 | WO |
0272182 | Sep 2002 | WO |
0390833 | Nov 2003 | WO |
2004032990 | Apr 2004 | WO |
2004105841 | Dec 2004 | WO |
2005018703 | Mar 2005 | WO |
2005037350 | Apr 2005 | WO |
2006037434 | Apr 2006 | WO |
2006069380 | Jun 2006 | WO |
2006102676 | Sep 2006 | WO |
2006104806 | Oct 2006 | WO |
2007051563 | May 2007 | WO |
2007056504 | May 2007 | WO |
2007092618 | Aug 2007 | WO |
2007130868 | Nov 2007 | WO |
2008001377 | Jan 2008 | WO |
2008014908 | Feb 2008 | WO |
2008024810 | Feb 2008 | WO |
2008024814 | Feb 2008 | WO |
2008057976 | May 2008 | WO |
2008072229 | Jun 2008 | WO |
2008076459 | Jun 2008 | WO |
2008078318 | Jul 2008 | WO |
2008129549 | Oct 2008 | WO |
2009046989 | Apr 2009 | WO |
2009044401 | Apr 2009 | WO |
2009081262 | Jul 2009 | WO |
2009125398 | Oct 2009 | WO |
2009144085 | Dec 2009 | WO |
2010078227 | Jul 2010 | WO |
2010078242 | Jul 2010 | WO |
2011034799 | Mar 2011 | WO |
2011075105 | Jun 2011 | WO |
2011090955 | Jul 2011 | WO |
2011090956 | Jul 2011 | WO |
2011113806 | Sep 2011 | WO |
2011156373 | Dec 2011 | WO |
2012040528 | Mar 2012 | WO |
2012032411 | Mar 2012 | WO |
2012160157 | Nov 2012 | WO |
2012160160 | Nov 2012 | WO |
2013115843 | Aug 2013 | WO |
2013148270 | Oct 2013 | WO |
2013148435 | Oct 2013 | WO |
2013173092 | Nov 2013 | WO |
2014070453 | May 2014 | WO |
2014107408 | Jul 2014 | WO |
2014179210 | Nov 2014 | WO |
2014179774 | Nov 2014 | WO |
Entry |
---|
Office Action dated Oct. 11, 2017 in U.S. Appl. No. 29/605,061, by Cabiri. |
Office Action dated Oct. 28, 2011 in U.S. Appl. No. 12/615,828. |
Office Action dated Oct. 28, 2015 in U.S. Appl. No. 13/429,942 by Cabiri. |
Office Action dated Oct. 5, 2017 in U.S. Appl. No. 29/605,068, by Cabiri. |
Office Action dated Oct. 6, 2017 in U.S. Appl. No. 29/604,616, by Cabiri. |
Office Action dated Oct. 6, 2017 in U.S. Appl. No. 29/605,051, by Cabiri. |
Office Action dated Oct. 9, 2014 in U.S. Appl. No. 13/873,335. |
Office Action dated Sep. 13, 2017 in EP Application No. 13783458.6. |
Office Action dated Sep. 18, 2015 in U.S. Appl. No. 13/874,085 by Cabiri. |
Office Action dated Sep. 2, 2010 in U.S. Appl. No. 12/244,688 by Gross. |
Office Action dated Sep. 2, 2014 in JP Application No. 2012-550068. |
Office Action dated Sep. 2, 2014 in JP Application No. 2012-550069. |
Office Action dated Sep. 29, 2013 in CN Application No. 201080040968.7. |
Office Action dated Sep. 30, 2010 in U.S. Appl. No. 12/689,250, by Cabiri. |
Office Action dated Sep. 30, 2015 in U.S. Appl. No. 13/667,739 by Cabiri. |
Office Action dated Sep. 6, 2011 in U.S. Appl. No. 12/345,818. |
Office Action dated Sep. 9, 2015 in U.S. Appl. No. 13/643,470 by Alon. |
Office Action dated Feb. 19, 2016 in U.S. Appl. No. 14/553,399 by Cabiri. |
Office Action dated Feb. 3, 2016 in U.S. Appl. No. 14/931,439 by Cabiri. |
Office Action dated Jul. 1, 2016 in U.S. Appl. No. 15/132,740 by Cabiri. |
Office Action dated Jul. 8, 2016 in CN Application No. 201510695320.8. |
Office Action dated May 4, 2016 in U.S. Appl. No. 15/069,080 by Cabiri. |
Office Action dated Nov. 6, 2015 in U.S. Appl. No. 14/715,791 by Cabiri. |
U.S. Appl. No. 12/559,563, filed Sep. 15, 2009. |
U.S. Appl. No. 12/689,249, filed Jan. 19, 2010. |
U.S. Appl. No. 12/689,250, filed Jan. 19, 2010. |
U.S. Appl. No. 13/429,840 by Cabiri, filed Mar. 26, 2012. |
U.S. Appl. No. 13/429,942 by Cabiri, filed Mar. 26, 2012. |
U.S. Appl. No. 13/472,112 by Cabiri, filed May 15, 2012. |
U.S. Appl. No. 13/521,167 by Cabiri, filed Jul. 9, 2012. |
U.S. Appl. No. 13/521,181 by Cabiri, filed Jul. 9, 2012. |
U.S. Appl. No. 13/643,470 by Alon, filed Oct. 25, 2012. |
U.S. Appl. No. 13/733,516 by Cabiri, filed Jan. 3, 2013. |
U.S. Appl. No. 13/873,335 by Filman, filed Apr. 30, 2013. |
U.S. Appl. No. 13/874,017 by Cabiri, filed Apr. 30, 2013. |
U.S. Appl. No. 13/874,085 by Cabiri, filed Apr. 30, 2013. |
U.S. Appl. No. 13/874,121 by Degtiar, filed Apr. 30, 2013. |
U.S. Appl. No. 13/886,867 by Cabiri, filed May 3, 2013. |
U.S. Appl. No. 13/892,905 by Cabiri, filed May 13, 2013. |
U.S. Appl. No. 13/964,651 by Gross, filed Aug. 12, 2013. |
U.S. Appl. No. 14/193,692 by Gross, filed Feb. 28, 2014. |
U.S. Appl. No. 14/258,661 by Cabiri, filed Apr. 22, 2014. |
U.S. Appl. No. 14/372,384 by Cabiri, filed Jul. 15, 2014. |
U.S. Appl. No. 14/553,399 by Cabiri, filed Nov. 25, 2014. |
U.S. Appl. No. 14/593,041 by Cabiri, filed Jan. 9, 2015. |
U.S. Appl. No. 14/593,051 by Gross, filed Jan. 9, 2015. |
U.S. Appl. No. 14/638,525 by Filman, filed Mar. 4, 2015. |
U.S. Appl. No. 14/683,193 by Cabiri, filed Apr. 10, 2015. |
U.S. Appl. No. 14/715,791 by Cabiri, filed May 19, 2015. |
U.S. Appl. No. 14/725,009 by Bar-El, filed May 29, 2015. |
Office Action dated Jul. 9, 2020 in European Application No. 16828833.0. |
Office Action dated Sep. 29, 2019 in JP Application No. 2019-505206. |
Office Action dated Sep. 27, 2020 in Chinese Application No. 201680088261.0. |
Copaxone(Registered), Innovative Drugs, Teva Pharmaceuticals, downloaded from webpage http://levapharm.com/copaxone/, Download date: Jan. 2009, original posting date: unknown, 3 pages. |
Daikyo Crystal Zenith(Registered) polymer, Manufactured by Daikyo Seiko, Lid. (Jun. 25, 2008). |
English translation of an Office Action dated Jan. 30, 2013 in CN Application No. 200880117084.X. |
English translation of an Office Action dated Mar. 5, 2014 in CN Application No. 200880117084.X. |
Extended European Search Report dated Aug. 7, 2014 in EP Application No. 1417477.4. |
Extended European Search Report dated Feb. 23, 2015 in EP Application No. 14166591.9. |
Extended European Search Report dated Feb. 23, 2015 in EP Application No. 14166596.8. |
Extended European Search Report dated Mar. 27, 2014 in EP Application No. 14154717.4. |
Int'l Preliminary Report on Patentability dated Oct. 9, 2014 in Int'l Application No. PCT/US 13/31598. |
Int'l Preliminary Report on Patentability dated Nov. 12, 2015 in Int'l Application No. PCT/US14/35662. |
Int'l Search Report and Written Opinion dated Jan. 12, 2011 in Int'l Application No. PCT/US2010/048556; Written Opinion. |
Int'l Preliminary Report on Patentability dated Apr. 7, 2010 in Int'l Application No. PCT/IL2008/001312. |
Int'l Preliminary Report on Patentability dated Aug. 14, 2014 in Int'l Application No. PCT/US2012/050696. |
Int'l Preliminary Report on Patentability dated Aug. 2, 2012 in Int'l Application No. PCT/US2011/021604. |
Int'l Preliminary Report on Patentability dated Feb. 7, 2013 in Int'l Application No. PCT/US11/21605. |
Int'l Preliminary Report on Patentability dated Jul. 16, 2015 in Int'l Application No. PCT/US2013/078040. |
Int'l Preliminary Report on Patentability dated May 14, 2015 in Int'l Application No. PCT/US2013/065211. |
Int'l Preliminary Report on Patentability dated Nov. 27, 2014 in Int'l Application No. PCT/US2013/039465. |
Int'l Preliminary Report on Patentability dated Oct. 9, 2014 in Int'l Application No. PCT/US2013/033118. |
Int'l Preliminary Report on Patentability dated Sep. 1, 2011 in Int'l Application No. PCT/US2010/048556. |
Int'l Search Report and Written Opinion dated Apr. 3, 2014 in Int'l Application No. PCT/US2013/078040. |
Int'l Search Report and Written Opinion dated Apr. 5, 2013 in Int'l Application No. PCT/US2012/050696. |
Int'l Search Report and Written Opinion dated Aug. 28, 2014 in Int'l Application No. PCT/US2014/035662. |
Int'l Search Report and Written Opinion dated Aug. 5, 2013 in Int'l Application No. PCT/US2013/033118. |
Int'l Search Report and Written Opinion dated Jan. 7, 2014 in Int'l Application No. PCT/US2013/065211. |
Int'l Search Report and Written Opinion dated Jul. 26, 2013 in Int'l Application No. PCT/US2012/039465. |
Int'l Search Report and Written Opinion dated Jul. 31, 2014 in Int'l Application No. PCT/US2014/033598. |
Int'l Search Report and Written Opinion dated Jun. 30, 2014 in Int'l Application No. PCT/US2013/031598. |
Int'l Search Report and Written Opinion dated May 13, 2009 in Int'l Application No. PCT/IL2008/001312. |
Int'l Search Report dated Apr. 26, 2010 in Int'l Application No. PCT/US2009/069552. |
Int'l Search Report dated Jun. 17, 2011 in Int'l Application No. PCT/US2011/021604. |
Int'l Search Report dated Oct. 12, 2011 in Int'l Application No. PCT/US11/21605. |
Int'l Search Report dated Sep. 22, 2011 in Int'l Application No. PCT/IL11/00368; Written Opinion. |
International Preliminary Report on Patentability and Written Opinion dated Jul. 5, 2011 in International Application No. PCT/US2009/069552. |
Notice of Allowance dated Aug. 24, 2015 in U.S. Appl. No. 29/479,307 by Norton. |
Notice of Allowance dated Apr. 25, 2016 in U.S. Appl. No. 14/553,399 by Cabiri. |
Notice of Allowance dated May 11, 2016 in U.S. Appl. No. 14/931,439 by Cabiri. |
Offce Action dated Sep. 21, 2010 in U.S. Appl. No. 12/244,666 by Gross. |
Office Action dated Apr. 19, 2016 in U.S. Appl. No. 14/372,384 by Cabiri. |
Office Action dated Apr. 24, 2013 in CN Application No. 201080040968.7. |
Office Action dated Apr. 5, 2010 in U.S. Appl. No. 12/244,666 by Gross. |
Office Action dated Apr. 5, 2010 in U.S. Appl. No. 12/244,688 by Gross. |
Office Action dated Aug. 13, 2015 in U.S. Appl. No. 14/553,399 by Cabiri. |
Office Action dated Aug. 13, 2018 in IN Application No. 857/KOLNP/2012. |
Office Action dated Aug. 15, 2013 in CN Application No. 200880117084.X. |
Office Action dated Aug. 15, 2013 in U.S. Appl. No. 13/429,942 by Cabiri. |
Office Action dated Aug. 26, 2014 in CN Application No. 201180006567.4. |
Office Action dated Aug. 6, 2014 in EP Appl. No. 11 707 942.6. |
Office Action dated Dec. 10, 2013 in CN Application No. 201180006567.4. |
Office Action dated Dec. 17, 2013 in JP Application No. 2012-529808. |
Int'l Search Report and Written Opinion dated Apr. 26, 2017 in Int'l Application No. PCT/US2016/068049. |
Office Action dated Dec. 29, 2016 in CN Application No. 2015106953208. |
Office Action dated Dec. 3, 2015 in CN Application No. 201280068544.0. |
Office Action dated Feb. 20, 2015 in U.S. Appl. No. 13/521,181 by Cabiri. |
Office Action dated Feb. 21, 2012 in U.S. Appl. No. 12/689,249. |
Office Action dated Feb. 24, 2015 in U.S. Appl. No. 14/258,661 by Cabiri. |
Office Action dated Feb. 24, 2016 in U.S. Appl. No. 13/429,942 by Cabiri. |
Office Action dated Feb. 28, 2014 in CN Application No. 201180006571.0. |
Office Action dated Feb. 4, 2014 in EP Application No. 11 707 942.6. |
Office Action dated Jan. 15, 2016 in U.S. Appl. No. 13/472,112 by Cabiri. |
Office Action dated Jan. 16, 2014 in U.S. Appl. No. 13/429,942 by Cabiri. |
Office Action dated Jan. 28, 2015 in U.S. Appl. No. 13/429,942 by Cabiri. |
Office Action dated Jan. 4, 2016 in U.S. Appl. No. 13/892,905 by Cabiri. |
Office Action dated Jan. 5, 2016 in U.S. Appl. No. 14/696,644 by Cabiri. |
Office Action dated Jan. 8, 2013 in JP Application No. 2010-527595. |
Office Action dated Jan. 8, 2014 in U.S. Appl. No. 13/521,167 by Cabiri. |
Office Action dated Jul. 13, 2011 in U.S. Appl. No. 12/559,563 by Cabiri. |
Office Action dated Jul. 2, 2012 in U.S. Appl. No. 13/272,555 by Cabiri. |
Office Action dated Jul. 29, 2013 in JP Application No. 2012-529808. |
Office Action dated Jul. 29, 2016 in U.S. Appl. No. 14/696,644, by Cabiri. |
Office Action dated Jul. 31, 2015 in U.S. Appl. No. 13/521,181 by Cabiri. |
Office Action dated Jul. 7, 2014 in U.S. Appl. No. 12/244,666 by Gross. |
Office Action dated Jul. 7, 2016 in U.S. Appl. No. 13/892,905 by Cabiri. |
Office Action dated Jun. 1, 2016 in CN Application No. 2013800274556. |
Office Action dated Jun. 17, 2016 in CN Application No. 201280068544.0. |
Office Action dated Jun. 3, 2014 in JP Application No. 2010-527595. |
Office Action dated Jun. 4, 2015 in U.S. Appl. No. 13/667,739 by Cabiri. |
Office Action dated Mar. 10, 2015 in CN Application No. 201180006567.4. |
Office Action dated Mar. 10, 2015 in U.S. Appl. No. 12/244,666 by Gross. |
Office Action dated Mar. 10, 2015 in U.S. Appl. No. 13/643,470 by Alon. |
Office Action dated Mar. 15, 2018 in U.S. Appl. No. 29/628,592 by Cabiri. |
Office Action dated Mar. 31, 2015 in JP Application No. 2012-550068. |
Office Action dated May 1, 2015 in U.S. Appl. No. 14/638,525 by Filman. |
Office Action dated May 13, 2015 in CN Application No. 201380025566.3. |
Office Action dated May 16, 2012 in U.S. Appl. No. 12/615,828. |
Office Action dated May 17, 2016 in U.S. Appl. No. 13/886,867 by Cabiri. |
Office Action dated May 18, 2015 in U.S. Appl. No. 13/429,942 by Cabiri. |
Office Action dated May 18, 2016 in U.S. Appl. No. 13/667,739 by Cabiri. |
Office Action dated May 23, 2014 in U.S. Appl. No. 13/472,112 by Cabiri. |
Office Action dated May 24, 2017 in CN Application No. 2013800571961. |
Office Action dated May 3, 2012 in CN Application No. 200880117084.X. |
Office Action dated May 7, 2015 in JP Application No. 2012-550069. |
Office Action dated Nov. 16, 2015 in U.S. Appl. No. 13/733,516 by Cabiri. |
Office Action dated Nov. 2, 2014 in CN Application No. 201180006571.0. |
Office Action dated Nov. 2, 2016 in CN Application No. 2013800571961. |
Office Action dated Nov. 21, 2014 in U.S. Appl. No. 13/429,840 by Cabiri. |
Office Action dated Nov. 21, 2014 in U.S. Appl. No. 13/472,112 by Cabiri. |
Office Action dated Nov. 25, 2015 in U.S. Appl. No. 14/372,384 by Cabiri. |
Office Action dated Nov. 4, 2013 in EP Application No. 11 709 234.6. |
Office Action dated Nov. 5, 2013 in JP Application No. 2010-527595. |
Office Action dated Nov. 5, 2014 in U.S. Appl. No. 13/643,470 by Alon. |
U.S. Appl. No. 14/850,450 by Gross, filed Sep. 10, 2015. |
U.S. Appl. No. 14/861,478 by Cabiri, filed Sep. 22, 2015. |
U.S. Appl. No. 14/880,673 by Cabiri, filed Oct. 12, 2015. |
U.S. Appl. No. 14/931,439 by Cabiri, filed Nov. 3, 2015. |
U.S. Appl. No. 15/196,775 by Cabiri, filed Jun. 29, 2016. |
U.S. Appl. No. 29/479,307 by Norton, filed Jan. 14, 2014. |
U.S. Appl. No. 60/997,459, filed Oct. 2, 2007. |
Number | Date | Country | |
---|---|---|---|
20190151562 A1 | May 2019 | US |
Number | Date | Country | |
---|---|---|---|
62369505 | Aug 2016 | US |